Recent insider trading activity from Meyers Steve Lawrence, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Meyers Steve Lawrence | Chief Commercial Officer | A | Common Stock | 64900 | $0.00 | 217,628.0000 | 187,241,483 | 42.49% | 0.03% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Meyers Steve Lawrence | Chief Commercial Officer | A | Stock Option (Right to Buy) | 197650 | $0.00 | 197,650.0000 | 187,241,483 | 9999.99% | 0.11% |